Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderly.

by Lisa J McGarry, Girishanthy Krishnarajah, Gregory Hill, Michelle Skornicki, Narin Pruttivarasin, Cristina Masseria, Bhakti Arondekar, Stephen I Pelton, Milton C Weinstein
Published 2013-01-01

Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission.

by Lisa J McGarry, Girishanthy Krishnarajah, Gregory Hill, Cristina Masseria, Michelle Skornicki, Narin Pruttivarasin, Bhakti Arondekar, Julie Roiz, Stephen I Pelton, Milton C Weinstein
Published 2014-01-01